[The treatment of patients with affective disorders with ethylnorantifeine].
D000275:Adjustment Disorders / Q000188:drug therapy; D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects; D000328:Adult; D000339:Affect / Q000187:drug effects*; D000368:Aged; D001007:Anxiety / Q000187:drug effects; D001714:Bipolar Disorder / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D001925:Brain Damage, Chronic / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000627:therapeutic use*; D005239:Fear / Q000187:drug effects; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D002537:Intracranial Arteriosclerosis / Q000150:complications; D008875:Middle Aged; D009043:Motor Activity / Q000187:drug effects; D011618:Psychotic Disorders / Q000188:drug therapy*; D013959:Thyroid Diseases / Q000188:drug therapy
D000697:Central Nervous System Stimulants; D007093:Imidazoles
Lechenie étilnorantifeinom bol'nykh s affektivnymi rasstroĭstvami.